Table Of Contents:
- Chapter 1. Research Methodology and Scope
- Market Segmentation and Scope
- Regional Coverage
- Objectives
- Research Methodology
- Chapter 2. Executive Summary
- Market Landscape
- Market Size & Forecast
- Competitive Landscape
- Chapter 3. Soft Tissue Sarcoma Market: By Product Type
- Chemotherapeutic Agents Market Size (US$), CAGR (%), and Forecast (2021-2031)
- Chemotherapeutic Agents Definitions, Technology Landscape
- Chemotherapeutic Agents Market Drivers
- Product Launches
- Technology Launches
- Chemotherapeutic Agents Market Restraints
- Targeted Therapies Market Size (US$), CAGR (%), and Forecast (2021-2031)
- Targeted Therapies Definitions, Technology Landscape
- Targeted Therapies Market Drivers
- Product Launches
- Technology Launches
- Targeted Therapies Market Restraints
- Immunotherapies Market Size (US$), CAGR (%), and Forecast (2021-2031)
- Immunotherapies Definitions, Technology Landscape
- Immunotherapies Market Drivers
- Product Launches
- Technology Launches
- Immunotherapies Market Restraints
- Radiation Therapy Market Size (US$), CAGR (%), and Forecast (2021-2031)
- Radiation Therapy Definitions, Technology Landscape
- Radiation Therapy Market Drivers
- Product Launches
- Technology Launches
- Radiation Therapy Market Restraints
- Surgical Devices Market Size (US$), CAGR (%), and Forecast (2021-2031)
- Surgical Devices Definitions, Technology Landscape
- Surgical Devices Market Drivers
- Product Launches
- Technology Launches
- Surgical Devices Market Restraints
- Diagnostic Imaging Equipment Market Size (US$), CAGR (%), and Forecast (2021-2031)
- Diagnostic Imaging Equipment Definitions, Technology Landscape
- Diagnostic Imaging Equipment Market Drivers
- Product Launches
- Technology Launches
- Diagnostic Imaging Equipment Market Restraints
- Others (e.g., Supportive Care Products) Market Size (US$), CAGR (%), and Forecast (2021-2031)
- Others (e.g., Supportive Care Products) Definitions, Technology Landscape
- Others (e.g., Supportive Care Products) Market Drivers
- Product Launches
- Technology Launches
- Others (e.g., Supportive Care Products) Market Restraints
- Chapter 4. Soft Tissue Sarcoma Market: By End-User
- Hospitals Market Size (US$), CAGR (%), and Forecast (2021-2031)
- Hospitals Definitions, Technology Landscape
- Hospitals Market Drivers
- Product Launches
- Technology Launches
- Hospitals Market Restraints
- Oncology Centers Market Size (US$), CAGR (%), and Forecast (2021-2031)
- Oncology Centers Definitions, Technology Landscape
- Oncology Centers Market Drivers
- Product Launches
- Technology Launches
- Oncology Centers Market Restraints
- Ambulatory Surgical Centers Market Size (US$), CAGR (%), and Forecast (2021-2031)
- Ambulatory Surgical Centers Definitions, Technology Landscape
- Ambulatory Surgical Centers Market Drivers
- Product Launches
- Technology Launches
- Ambulatory Surgical Centers Market Restraints
- Research Institutes Market Size (US$), CAGR (%), and Forecast (2021-2031)
- Research Institutes Definitions, Technology Landscape
- Research Institutes Market Drivers
- Product Launches
- Technology Launches
- Research Institutes Market Restraints
- Home Care Settings Market Size (US$), CAGR (%), and Forecast (2021-2031)
- Home Care Settings Definitions, Technology Landscape
- Home Care Settings Market Drivers
- Product Launches
- Technology Launches
- Home Care Settings Market Restraints
- Others (e.g., Specialty Clinics) Market Size (US$), CAGR (%), and Forecast (2021-2031)
- Others (e.g., Specialty Clinics) Definitions, Technology Landscape
- Others (e.g., Specialty Clinics) Market Drivers
- Product Launches
- Technology Launches
- Others (e.g., Specialty Clinics) Market Restraints
- Chapter 5. Soft Tissue Sarcoma Market: By Soft Tissue Sarcoma Type
- Liposarcoma Market Size (US$), CAGR (%), and Forecast (2021-2031)
- Liposarcoma Definitions, Technology Landscape
- Liposarcoma Market Drivers
- Product Launches
- Technology Launches
- Liposarcoma Market Restraints
- Leiomyosarcoma Market Size (US$), CAGR (%), and Forecast (2021-2031)
- Leiomyosarcoma Definitions, Technology Landscape
- Leiomyosarcoma Market Drivers
- Product Launches
- Technology Launches
- Leiomyosarcoma Market Restraints
- Undifferentiated Pleomorphic Sarcoma Market Size (US$), CAGR (%), and Forecast (2021-2031)
- Undifferentiated Pleomorphic Sarcoma Definitions, Technology Landscape
- Undifferentiated Pleomorphic Sarcoma Market Drivers
- Product Launches
- Technology Launches
- Undifferentiated Pleomorphic Sarcoma Market Restraints
- Synovial Sarcoma Market Size (US$), CAGR (%), and Forecast (2021-2031)
- Synovial Sarcoma Definitions, Technology Landscape
- Synovial Sarcoma Market Drivers
- Product Launches
- Technology Launches
- Synovial Sarcoma Market Restraints
- Malignant Peripheral Nerve Sheath Tumor Market Size (US$), CAGR (%), and Forecast (2021-2031)
- Malignant Peripheral Nerve Sheath Tumor Definitions, Technology Landscape
- Malignant Peripheral Nerve Sheath Tumor Market Drivers
- Product Launches
- Technology Launches
- Malignant Peripheral Nerve Sheath Tumor Market Restraints
- Rhabdomyosarcoma Market Size (US$), CAGR (%), and Forecast (2021-2031)
- Rhabdomyosarcoma Definitions, Technology Landscape
- Rhabdomyosarcoma Market Drivers
- Product Launches
- Technology Launches
- Rhabdomyosarcoma Market Restraints
- Others (e.g., Fibrosarcoma, Angiosarcoma, Epithelioid Sarcoma) Market Size (US$), CAGR (%), and Forecast (2021-2031)
- Others (e.g., Fibrosarcoma, Angiosarcoma, Epithelioid Sarcoma) Definitions, Technology Landscape
- Others (e.g., Fibrosarcoma, Angiosarcoma, Epithelioid Sarcoma) Market Drivers
- Product Launches
- Technology Launches
- Others (e.g., Fibrosarcoma, Angiosarcoma, Epithelioid Sarcoma) Market Restraints
- Chapter 6. Soft Tissue Sarcoma Market: By Treatment Modality
- Chemotherapy Market Size (US$), CAGR (%), and Forecast (2021-2031)
- Chemotherapy Definitions, Technology Landscape
- Chemotherapy Market Drivers
- Product Launches
- Technology Launches
- Chemotherapy Market Restraints
- Targeted Therapy Market Size (US$), CAGR (%), and Forecast (2021-2031)
- Targeted Therapy Definitions, Technology Landscape
- Targeted Therapy Market Drivers
- Product Launches
- Technology Launches
- Targeted Therapy Market Restraints
- Immunotherapy Market Size (US$), CAGR (%), and Forecast (2021-2031)
- Immunotherapy Definitions, Technology Landscape
- Immunotherapy Market Drivers
- Product Launches
- Technology Launches
- Immunotherapy Market Restraints
- Radiation Therapy Market Size (US$), CAGR (%), and Forecast (2021-2031)
- Radiation Therapy Definitions, Technology Landscape
- Radiation Therapy Market Drivers
- Product Launches
- Technology Launches
- Radiation Therapy Market Restraints
- Surgery Market Size (US$), CAGR (%), and Forecast (2021-2031)
- Surgery Definitions, Technology Landscape
- Surgery Market Drivers
- Product Launches
- Technology Launches
- Surgery Market Restraints
- Combination Therapy Market Size (US$), CAGR (%), and Forecast (2021-2031)
- Combination Therapy Definitions, Technology Landscape
- Combination Therapy Market Drivers
- Product Launches
- Technology Launches
- Combination Therapy Market Restraints
- Others (e.g., Palliative Care) Market Size (US$), CAGR (%), and Forecast (2021-2031)
- Others (e.g., Palliative Care) Definitions, Technology Landscape
- Others (e.g., Palliative Care) Market Drivers
- Product Launches
- Technology Launches
- Others (e.g., Palliative Care) Market Restraints
- Chapter 7. Soft Tissue Sarcoma Market: By Distribution Channel
- Hospital Pharmacies Market Size (US$), CAGR (%), and Forecast (2021-2031)
- Hospital Pharmacies Definitions, Technology Landscape
- Hospital Pharmacies Market Drivers
- Product Launches
- Technology Launches
- Hospital Pharmacies Market Restraints
- Retail Pharmacies Market Size (US$), CAGR (%), and Forecast (2021-2031)
- Retail Pharmacies Definitions, Technology Landscape
- Retail Pharmacies Market Drivers
- Product Launches
- Technology Launches
- Retail Pharmacies Market Restraints
- Online Pharmacies Market Size (US$), CAGR (%), and Forecast (2021-2031)
- Online Pharmacies Definitions, Technology Landscape
- Online Pharmacies Market Drivers
- Product Launches
- Technology Launches
- Online Pharmacies Market Restraints
- Direct-to-Consumer Market Size (US$), CAGR (%), and Forecast (2021-2031)
- Direct-to-Consumer Definitions, Technology Landscape
- Direct-to-Consumer Market Drivers
- Product Launches
- Technology Launches
- Direct-to-Consumer Market Restraints
- Others (e.g., Specialty Pharmacies) Market Size (US$), CAGR (%), and Forecast (2021-2031)
- Others (e.g., Specialty Pharmacies) Definitions, Technology Landscape
- Others (e.g., Specialty Pharmacies) Market Drivers
- Product Launches
- Technology Launches
- Others (e.g., Specialty Pharmacies) Market Restraints
- Chapter 8. Soft Tissue Sarcoma Market: Regional Market Trends, Size, and Future Outlook
- North America Trends, Market Size (US$), CAGR (%), and Future Outlook
- North America Market Size (US$), CAGR (%), and Forecast (2021-2031)
- North America Definitions, Technology Landscape
- North America Market Drivers
- Product Launches
- Technology Launches
- North America Market Restraints
- Competitive Outlook
- Europe Trends, Market Size (US$), CAGR (%), and Future Outlook
- Europe Market Size (US$), CAGR (%), and Forecast (2021-2031)
- Europe Definitions, Technology Landscape
- Europe Market Drivers
- Product Launches
- Technology Launches
- Europe Market Restraints
- Competitive Outlook
- Asia Pacific Trends, Market Size (US$), CAGR (%), and Future Outlook
- Asia Pacific Market Size (US$), CAGR (%), and Forecast (2021-2031)
- Asia Pacific Definitions, Technology Landscape
- Asia Pacific Market Drivers
- Product Launches
- Technology Launches
- Asia Pacific Market Restraints
- Competitive Outlook
- Latin America Trends, Market Size (US$), CAGR (%), and Future Outlook
- Latin America Market Size (US$), CAGR (%), and Forecast (2021-2031)
- Latin America Definitions, Technology Landscape
- Latin America Market Drivers
- Product Launches
- Technology Launches
- Latin America Market Restraints
- Competitive Outlook
- Middle East & Africa Trends, Market Size (US$), CAGR (%), and Future Outlook
- Middle East & Africa Market Size (US$), CAGR (%), and Forecast (2021-2031)
- Middle East & Africa Definitions, Technology Landscape
- Middle East & Africa Market Drivers
- Product Launches
- Technology Launches
- Middle East & Africa Market Restraints
- Competitive Outlook
- Soft Tissue Sarcoma Market: Competitive Landscape
- Novartis AG
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Pfizer Inc.
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Bayer AG
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Merck & Co., Inc.
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- GlaxoSmithKline plc
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Eli Lilly and Company
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Takeda Pharmaceutical Company Limited
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- AstraZeneca plc
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Bristol-Myers Squibb Company
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Johnson & Johnson
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Amgen Inc.
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Daiichi Sankyo Company, Limited
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Teva Pharmaceutical Industries Ltd.
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Boehringer Ingelheim International GmbH
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Myriad Genetics, Inc.
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Novartis AG
Research Methodology
- Primary Research
- Secondary Research
- Assumptions
- IDataAcumen Analysis
- Paid Databases
Appendix
- About Us
Frequently Asked Questions
The current market size of the Soft Tissue Sarcoma industry is US$ 6,400 million.
Increasing incidence of soft tissue sarcomas, advancements in diagnostic techniques, growing adoption of targeted therapies, rise in geriatric population, shift towards personalized medicine, integration of AI and ML in diagnosis and treatment, expansion of immunotherapy pipeline, and focus on rare and orphan soft tissue sarcoma subtypes.
Complexity of disease and treatment challenges, high cost of targeted therapies, limited access to healthcare in developing regions, and lack of awareness and delayed diagnosis.
The leading component segment in the Soft Tissue Sarcoma Market is the Targeted Therapies segment, which is expected to dominate the market due to the increasing adoption of personalized medicine approaches and the development of novel targeted agents.
The major players operating in the Soft Tissue Sarcoma Market include Novartis AG, Pfizer Inc., Bayer AG, Merck & Co., Inc., GlaxoSmithKline plc, Eli Lilly and Company, Takeda Pharmaceutical Company Limited, AstraZeneca plc, Bristol-Myers Squibb Company, and Johnson & Johnson, among others.
The CAGR of the Soft Tissue Sarcoma Market is expected to be 5.8% from 2024 to 2031, with a market size of US$ 10,047.7 million by 2031.
The key drivers of the Soft Tissue Sarcoma Market include increasing incidence of soft tissue sarcomas, advancements in diagnostic techniques, growing adoption of targeted therapies, rise in geriatric population, shift towards personalized medicine, integration of AI and ML in diagnosis and treatment, expansion of immunotherapy pipeline, and focus on rare and orphan soft tissue sarcoma subtypes.